Vnir Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.12 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -7.36%
- Profit Growth -51.17%
- Ebitda -61.67%
- Net Worth 314.36%
- Total Assets 78.50%
About Vnir Biotechnologies
Vnir Biotechnologies Private Limited (VBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 April 2017 (Seven years and nine months 29 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Govindaraju Thimmaiah, Meher Ayalasomayajula, and Jagadeesh Daler serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73200KA2017PTC102171
-
Company No.
102171
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Apr 2017
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Vnir Biotechnologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindaraju Thimmaiah
|
Director | 11-Apr-2017 | Current |
|
Meher Ayalasomayajula
|
Director | 11-Apr-2017 | Current |
|
Jagadeesh Daler
|
Director | 10-Aug-2023 | Current |
Financial Performance of Vnir Biotechnologies.
Vnir Biotechnologies Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.36% decrease. The company also saw a substantial fall in profitability, with a 51.17% decrease in profit. The company's net worth Soared by an impressive increase of 314.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vnir Biotechnologies?
In 2022, Vnir Biotechnologies had a public holding of 23.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vnir Biotechnologies?
Unlock and access historical data on people associated with Vnir Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vnir Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vnir Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.